Your browser doesn't support javascript.
loading
ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice.
Bousquet, Jean; Anto, Josep M; Bachert, Claus; Haahtela, Tari; Zuberbier, Torsten; Czarlewski, Wienczyslawa; Bedbrook, Anna; Bosnic-Anticevich, Sinthia; Walter Canonica, G; Cardona, Victoria; Costa, Elisio; Cruz, Alvaro A; Erhola, Marina; Fokkens, Wytske J; Fonseca, Joao A; Illario, Maddalena; Ivancevich, Juan-Carlos; Jutel, Marek; Klimek, Ludger; Kuna, Piotr; Kvedariene, Violeta; Le, Ltt; Larenas-Linnemann, Désirée E; Laune, Daniel; Lourenço, Olga M; Melén, Erik; Mullol, Joaquim; Niedoszytko, Marek; Odemyr, Mikaëla; Okamoto, Yoshitaka; Papadopoulos, Nikos G; Patella, Vincenzo; Pfaar, Oliver; Pham-Thi, Nhân; Rolland, Christine; Samolinski, Boleslaw; Sheikh, Aziz; Sofiev, Mikhail; Suppli Ulrik, Charlotte; Todo-Bom, Ana; Tomazic, Peter-Valentin; Toppila-Salmi, Sanna; Tsiligianni, Ioanna; Valiulis, Arunas; Valovirta, Erkka; Ventura, Maria-Teresa; Walker, Samantha; Williams, Sian; Yorgancioglu, Arzu; Agache, Ioana.
Afiliação
  • Bousquet J; MACVIA-France and CHU, Montpellier, France.
  • Anto JM; INSERM U 1168, VIMA: Ageing and Chronic Diseases Epidemiological and Public Health Approaches, Villejuif, Université Versailles St-Quentin-en-Yvelines, UMR-S 1168, Montigny le Bretonneux, France, and Charité, Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health,
  • Bachert C; ISGlobAL, Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain.
  • Haahtela T; IMIM (Hospital del Mar Research Institute), Barcelona, Spain.
  • Zuberbier T; CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.
  • Czarlewski W; Universitat Pompeu Fabra (UPF), Barcelona, Spain.
  • Bedbrook A; Upper Airways Research Laboratory, ENT Department, Ghent University Hospital, Ghent, Belgium and Sun Yat-sen University, International Airway Research Center, First Affiliated Hospital Guangzou, China, and Division of ENT Diseases, CLINTEC, Karolinska Institutet, Stockholm and Department of ENT Dise
  • Bosnic-Anticevich S; Skin and Allergy Hospital, Helsinki University Hospital, and University of Helsinki, Helsinki, Finland.
  • Walter Canonica G; Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Uniersität zu Berlin and Berlin Institute of Health, Comprehensive Allergy-Centre, Department of Dermatology and Allergy, Member of GA2LEN, Berlin, Germany.
  • Cardona V; Medical Consulting Czarlewski, Levallois, and MASK-air, Montpellier, France.
  • Costa E; MACVIA-France and CHU, Montpellier, France.
  • Cruz AA; Woolcock Institute of Medical Research, University of Sydney and Woolcock Emphysema Centre and Sydney Local Health District, Glebe, NSW, Australia.
  • Erhola M; Personalized Medicine Clinic Asthma & Allergy, Humanitas Clinical and Research Center IRCCS, Rozzano and Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (MI), Italy.
  • Fokkens WJ; Allergy Section, Department of Internal Medicine, Hospital Vall d'Hebron & ARADyAL research network, Barcelona, Spain.
  • Fonseca JA; UCIBIO, REQUINTE, Faculty of Pharmacy and Competence Center on Active and Healthy Ageing of University of Porto (Porto4Ageing), Porto, Portugal.
  • Illario M; ProAR-Nucleo de Excelencia em Asma, Federal University of Bahia, Brasil and WHO GARD Planning Group, Brazil.
  • Ivancevich JC; National Insitute for Health and Welfare, Helsinki, Finland.
  • Jutel M; Department of Otorhinolaryngology, Academic Medical Centres, AMC, Amsterdam, the Netherlands, and Euforea, Brussels, Belgium.
  • Klimek L; CINTESIS, Center for Research in Health Technology and Information Systems, Faculdade de Medicina da Universidade do Porto; and Medida, Lda Porto, Portugal.
  • Kuna P; Division for Health Innovation, Campania Region and Federico II University Hospital Naples (R&D and DISMET), Naples, Italy.
  • Kvedariene V; Servicio de Alergia e Immunologia, Clinica Santa Isabel, Buenos Aires, Argentina.
  • Le L; Department of Clinical Immunology, Wroclaw Medical University and ALL-MED Medical Research Institute, Warsaw, Poland.
  • Larenas-Linnemann DE; Center for Rhinology and Allergology, Wiesbaden, Germany.
  • Laune D; Division of Internal Medicine, Asthma and Allergy, Barlicki University Hospital, Medical University of Lodz, Poland.
  • Lourenço OM; Institute of Biomedical Sciences, Department of Pathology, Faculty of Medicine, Vilnius University and Institute of Clinical Medicine, Clinic of Chest diseases and Allergology, Faculty of Medicine, Vilnius, Lithuania.
  • Melén E; University of Medicine and Pharmacy, Hochiminh City, Vietnam.
  • Mullol J; Center of Excellence in Asthma and Allergy, Médica Sur Clinical Foundation and Hospital, México City, Mexico.
  • Niedoszytko M; KYomed INNOV, Montpellier, France.
  • Odemyr M; Faculty of Health Sciences and CICS-UBI, Health Sciences Research Centre, University of Beira Interior, Covilhã, Portugal.
  • Okamoto Y; Sachs' Children and Youth Hospital, Södersjukhuset, Stockholm and Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Papadopoulos NG; Rhinology Unit & Smell Clinic, ENT Department, Hospital Clínic; Clinical & Experimental Respiratory Immunoallergy, IDIBAPS, CIBERES, University of Barcelona, Spain.
  • Patella V; Department of Allergology, Medical University of Gdansk, Gdansk, Poland.
  • Pfaar O; EFA European Federation of Allergy and Airways Diseases Patients' Associations, Brussels, Belgium.
  • Pham-Thi N; Dept of Otorhinolaryngology, Chiba University Hospital, Chiba, Japan.
  • Rolland C; Division of Infection, Immunity & Respiratory Medicine, Royal Manchester Children's Hospital, University of Manchester, Manchester, UK.
  • Samolinski B; Allergy Department, 2nd Pediatric Clinic, Athens General Children's Hospital "P&A Kyriakou", University of Athens, Athens, Greece.
  • Sheikh A; Division of Allergy and Clinical Immunology, Department of Medicine, Agency of Health ASL Salerno, "Santa Maria della Speranza" Hospital, Salerno, Italy.
  • Sofiev M; Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Philipps-Universität Marburg, Marburg, Germany.
  • Suppli Ulrik C; Ecole polytechnique, Palaiseau, IRBA (Institut de Recherche bio-Médicale des Armées, Bretigny), France.
  • Todo-Bom A; Association Asthme et Allergie, Paris, France.
  • Tomazic PV; Department of Prevention of Environmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland.
  • Toppila-Salmi S; The Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK.
  • Tsiligianni I; Finnish Meteorological Institute (FMI), Helsinki, Finland.
  • Valiulis A; Department of Respiratory Medicine, Hvidovre Hospital & University of Copenhagen, Copenhagen, Denmark.
  • Valovirta E; Allergy and Clinical Immunology Unit, Institute of Immunology, Faculty of Medicine, University of Coimbra, ICBR - Coimbra Institute for Clinical and Biomedical Research, CIBB, Coimbra, Portugal.
  • Ventura MT; Department of General ORL, H&NS, Medical University of Graz, Graz, Austria.
  • Walker S; Skin and Allergy Hospital, Helsinki University Hospital, and University of Helsinki, Helsinki, Finland.
  • Williams S; Health Planning Unit, Department of Social Medicine, Faculty of Medicine, University of Crete, Crete, Greece and International Primary Care Respiratory Group IPCRG, Aberdeen, Scotland.
  • Yorgancioglu A; Vilnius University Faculty of Medicine, Institute of Clinical Medicine & Institute of Health Sciences, Vilnius, Lithuania.
  • Agache I; Department of Lung Diseases and Clinical Immunology, University of Turku and Terveystalo Allergy Clinic, Turku, Finland.
Allergy ; 76(1): 168-190, 2021 01.
Article em En | MEDLINE | ID: mdl-32512619
Digital anamorphosis is used to define a distorted image of health and care that may be viewed correctly using digital tools and strategies. MASK digital anamorphosis represents the process used by MASK to develop the digital transformation of health and care in rhinitis. It strengthens the ARIA change management strategy in the prevention and management of airway disease. The MASK strategy is based on validated digital tools. Using the MASK digital tool and the CARAT online enhanced clinical framework, solutions for practical steps of digital enhancement of care are proposed.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Respiratórios / Asma / Rinite Alérgica Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos Respiratórios / Asma / Rinite Alérgica Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article